Cargando…

Urinary miRNA profile for the diagnosis of IgA nephropathy

BACKGROUND: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Urinary micro-RNA (miRNA) level is increasingly reported to as non-invasive markers of various kidney diseases. We aim to identify urinary miRNA targets for the diagnosis of IgAN. METHODS: In the development...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szeto, Cheuk-Chun, Wang, Gang, Ng, Jack Kit-Chung, Kwan, Bonnie Ching-Ha, Mac-Moune Lai, Fernand, Chow, Kai-Ming, Luk, Cathy Choi-Wan, Lai, Ka-Bik, Li, Philip Kam-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399975/ https://www.ncbi.nlm.nih.gov/pubmed/30832601 http://dx.doi.org/10.1186/s12882-019-1267-4

Ejemplares similares

Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2010)

Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2020)

Elevated Levels of miR-146a and miR-155 in Kidney Biopsy and Urine from Patients with IgA Nephropathy
por: Wang, Gang, et al.
Publicado: (2011)

Urinary Biomarkers for The Prediction of Reversibility in Acute-on-Chronic Renal Failure
por: Luk, Cathy Choi-Wan, et al.
Publicado: (2013)

Micro-RNA Expression in the Urinary Sediment of Patients with Chronic Kidney Diseases
por: Szeto, Cheuk-Chun, et al.
Publicado: (2012)

Functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients
por: Chow, Kai Ming, et al.
Publicado: (2015)

Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases
por: WEI, Zhongping, et al.
Publicado: (2018)

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis
por: Szeto, Cheuk-Chun, et al.
Publicado: (2023)

Relation between MicroRNA Expression in Peritoneal Dialysis Effluent and Peritoneal Transport Characteristics
por: Chen, Jin, et al.
Publicado: (2012)

Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2016)

Metabolomic Changes of Human Proximal Tubular Cell Line in High Glucose Environment
por: Wei, Pascal Zhongping, et al.
Publicado: (2019)

Author Correction: Metabolomic Changes of Human Proximal Tubular Cell Line in High Glucose Environment
por: Wei, Pascal Zhongping, et al.
Publicado: (2020)

Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy
por: Liang, Shuang, et al.
Publicado: (2017)

Urinary exosomal miRNA signature of IgA nephropathy: a case–control study
por: Shankar, Mythri, et al.
Publicado: (2023)

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy
por: Yang, Joshua Y. C., et al.
Publicado: (2019)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Recent advances in the understanding and management of IgA nephropathy
por: Lai, Kar Neng, et al.
Publicado: (2016)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy
por: Yiu, Wai Han, et al.
Publicado: (2021)

Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy
por: Seki, Takuto, et al.
Publicado: (2014)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy
por: Duan, Zhi-Yu, et al.
Publicado: (2018)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study
por: Szeto, Cheuk-Chun, et al.
Publicado: (2013)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy
por: Seo, Mi Seon, et al.
Publicado: (2013)

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
por: Wang, Nannan, et al.
Publicado: (2015)

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression
por: Zhao, Yanfeng, et al.
Publicado: (2015)

IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers
por: Yu, Byung Chul, et al.
Publicado: (2019)

Association between urinary VEGFA and renal pathology of IgA nephropathy patients
por: Feng, Shaozhen, et al.
Publicado: (2021)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ehukfv8vaet9d6irvl16tsf4p